3,439 research outputs found
Comparação de metodologia analĂtica na determinação de fĂłsforo em fertilizante
TCC (graduação) - Universidade Federal de Santa Catarina. Centro de CiĂȘncias FĂsicas e MatemĂĄticas. Curso de QuĂmica.Fertilizante Ă© toda substĂąncia mineral ou sintĂ©tica, fornecedora de um ou mais nutrientes e Ă© aplicado no solo para repor os nutrientes que ficam escassos pelo uso intensivo. O Brasil produz por ano, 300 milhĂ”es de toneladas de fertilizantes e para garantir a qualidade da produção e comercialização, conta com a colaboração do MinistĂ©rio da Agricultura, PecuĂĄria e Abastecimento (MAPA) e dos estados. Por isso, faz-se necessĂĄrio tambĂ©m a revisĂŁo das metodologias, tanto para seu aprimoramento como a inclusĂŁo de novas tĂ©cnicas. Neste trabalho, estĂŁo sendo avaliadas as metodologias para determinação de fĂłsforo solĂșvel em Citrato Neutro de AmĂŽnio pelo mĂ©todo gravimĂ©trico oficial adotado pelo MAPA, o mĂ©todo gravimĂ©trico simplificado e o mĂ©todo espectrofotomĂ©trico. Comparando o mĂ©todo gravimĂ©trico oficial, o mĂ©todo simplificado leva a metade do tempo para a determinação e metade dos reagentes, podendo substituĂ-lo com a mesma qualidade. Assim como o mĂ©todo espectrofotomĂ©trico tambĂ©m pode substituir o mĂ©todo oficial, diminuindo o tempo para realização das amostras fornecendo maior precisĂŁo aos resultados
Pé diabético na atenção båsica: uma revisão de literatura: Diabetic foot in primary care: a literature review
A diabetes se trata de uma patologia decorrente da descompensação da glicose, sendo por reação autoimune que danifica as cĂ©lulas de produção de insulina ou por resistĂȘncia insulĂnica de tecidos. O descontrole da glicose pode significar um grande perigo ao paciente diabĂ©tico, elevando o risco de sepse, neuropatias, dificultando a cicatrização e se agravando para a sĂndrome do PĂ© DiabĂ©tico. No mundo, sĂŁo mais de 40 milhĂ”es de pessoas com a sĂndrome do PĂ© DiabĂ©tico, se tratando de um problema de saĂșde pĂșblica pandĂȘmico. Alguns fatos como falta de conhecimento sobre o assunto, negligĂȘncia mĂ©dica, falta de acesso Ă saĂșde, nĂŁo seguimento das orientaçÔes passadas pela equipe de saĂșde da atenção bĂĄsica por parte do paciente ou nĂŁo reforçar a importĂąncia das orientaçÔes contribuem para o surgimento da sĂndrome. Logo Ă© importante saber os principais tĂłpicos em PĂ© DiabĂ©tico para o atendimento na Atenção BĂĄsica Ă SaĂșde para uma boa orientação para os pacientes.A diabetes se trata de uma patologia decorrente da descompensação da glicose, sendo por reação autoimune que danifica as cĂ©lulas de produção de insulina ou por resistĂȘncia insulĂnica de tecidos. O descontrole da glicose pode significar um grande perigo ao paciente diabĂ©tico, elevando o risco de sepse, neuropatias, dificultando a cicatrização e se agravando para a sĂndrome do PĂ© DiabĂ©tico. No mundo, sĂŁo mais de 40 milhĂ”es de pessoas com a sĂndrome do PĂ© DiabĂ©tico, se tratando de um problema de saĂșde pĂșblica pandĂȘmico. Alguns fatos como falta de conhecimento sobre o assunto, negligĂȘncia mĂ©dica, falta de acesso Ă saĂșde, nĂŁo seguimento das orientaçÔes passadas pela equipe de saĂșde da atenção bĂĄsica por parte do paciente ou nĂŁo reforçar a importĂąncia das orientaçÔes contribuem para o surgimento da sĂndrome. Logo Ă© importante saber os principais tĂłpicos em PĂ© DiabĂ©tico para o atendimento na Atenção BĂĄsica Ă SaĂșde para uma boa orientação para os pacientes
Measurement of the cosmic ray spectrum above eV using inclined events detected with the Pierre Auger Observatory
A measurement of the cosmic-ray spectrum for energies exceeding
eV is presented, which is based on the analysis of showers
with zenith angles greater than detected with the Pierre Auger
Observatory between 1 January 2004 and 31 December 2013. The measured spectrum
confirms a flux suppression at the highest energies. Above
eV, the "ankle", the flux can be described by a power law with
index followed by
a smooth suppression region. For the energy () at which the
spectral flux has fallen to one-half of its extrapolated value in the absence
of suppression, we find
eV.Comment: Replaced with published version. Added journal reference and DO
Energy Estimation of Cosmic Rays with the Engineering Radio Array of the Pierre Auger Observatory
The Auger Engineering Radio Array (AERA) is part of the Pierre Auger
Observatory and is used to detect the radio emission of cosmic-ray air showers.
These observations are compared to the data of the surface detector stations of
the Observatory, which provide well-calibrated information on the cosmic-ray
energies and arrival directions. The response of the radio stations in the 30
to 80 MHz regime has been thoroughly calibrated to enable the reconstruction of
the incoming electric field. For the latter, the energy deposit per area is
determined from the radio pulses at each observer position and is interpolated
using a two-dimensional function that takes into account signal asymmetries due
to interference between the geomagnetic and charge-excess emission components.
The spatial integral over the signal distribution gives a direct measurement of
the energy transferred from the primary cosmic ray into radio emission in the
AERA frequency range. We measure 15.8 MeV of radiation energy for a 1 EeV air
shower arriving perpendicularly to the geomagnetic field. This radiation energy
-- corrected for geometrical effects -- is used as a cosmic-ray energy
estimator. Performing an absolute energy calibration against the
surface-detector information, we observe that this radio-energy estimator
scales quadratically with the cosmic-ray energy as expected for coherent
emission. We find an energy resolution of the radio reconstruction of 22% for
the data set and 17% for a high-quality subset containing only events with at
least five radio stations with signal.Comment: Replaced with published version. Added journal reference and DO
Measurement of the Radiation Energy in the Radio Signal of Extensive Air Showers as a Universal Estimator of Cosmic-Ray Energy
We measure the energy emitted by extensive air showers in the form of radio
emission in the frequency range from 30 to 80 MHz. Exploiting the accurate
energy scale of the Pierre Auger Observatory, we obtain a radiation energy of
15.8 \pm 0.7 (stat) \pm 6.7 (sys) MeV for cosmic rays with an energy of 1 EeV
arriving perpendicularly to a geomagnetic field of 0.24 G, scaling
quadratically with the cosmic-ray energy. A comparison with predictions from
state-of-the-art first-principle calculations shows agreement with our
measurement. The radiation energy provides direct access to the calorimetric
energy in the electromagnetic cascade of extensive air showers. Comparison with
our result thus allows the direct calibration of any cosmic-ray radio detector
against the well-established energy scale of the Pierre Auger Observatory.Comment: Replaced with published version. Added journal reference and DOI.
Supplemental material in the ancillary file
High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer
Characteristic cytokine patterns have been described in different cancer patients and they are related to their diagnosis, prognosis, prediction of treatment responses and survival. A panel of cytokines was evaluated in the plasma of non-small cell lung cancer (NSCLC) patients and healthy controls to investigate their profile and relationship with clinical characteristics and overall survival. The case-controlled cross-sectional study design recruited 77 patients with confirmed diagnosis of NSCLC (cases) and 91 healthy subjects (controls) aimed to examine peripheral pro-inflammatory and anti-inflammatory cytokines (IL-2, IL-4, IL-6, IL-10, IL-17A, TNF and IFN-gamma) by Cytometry Beads Arrays (CBA Flex) in. The cytokine IL-6 showed a statistically significant difference among groups with increased expression in the case group (p < 0.001). The correlation between the cytokines expression with patient's clinical characteristics variables revealed the cytokine IL-6 was found to be associated with gender, showing higher levels in male (p = 0.036), whereas IL-17A levels were associated with TNM stage, being higher in III-IV stages (p = 0.044). We observed worse overall survival for individuals with high levels of IL-6 when compared to those with low levels of this cytokine in 6, 12 and 24 months. Further studies of IL-6 levels in independent cohort could clarify the real role of IL-6 as an independent marker of prognostic of NSCLC.Conselho Nacional de Desenvolvimento CientĂfico e TencnolĂłgico (CNPq) [Grant number 401775/2012-7 to ALF]; Fundação de Amparo Ă Pesquisa do Estado de SĂŁo Paulo (FAPESP) [Grant number 2014/ 23414-8 to EMS]info:eu-repo/semantics/publishedVersio
Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis
BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London
Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism
Background Atrial fibrillation (AF) may exist before or occur early in the course of pulmonary embolism (PE). We determined the PE outcomes based on the presence and timing of AF. Methods and Results Using the data from a multicenter PE registry, we identified 3 groups: (1) those with preexisting AF, (2) patients with new AF within 2 days from acute PE (incident AF), and (3) patients without AF. We assessed the 90-day and 1-year risk of mortality and stroke in patients with AF, compared with those without AF (reference group). Among 16 497 patients with PE, 792 had preexisting AF. These patients had increased odds of 90-day all-cause (odds ratio [OR], 2.81; 95% CI, 2.33-3.38) and PE-related mortality (OR, 2.38; 95% CI, 1.37-4.14) and increased 1-year hazard for ischemic stroke (hazard ratio, 5.48; 95% CI, 3.10-9.69) compared with those without AF. After multivariable adjustment, preexisting AF was associated with significantly increased odds of all-cause mortality (OR, 1.91; 95% CI, 1.57-2.32) but not PE-related mortality (OR, 1.50; 95% CI, 0.85-2.66). Among 16 497 patients with PE, 445 developed new incident AF within 2 days of acute PE. Incident AF was associated with increased odds of 90-day all-cause (OR, 2.28; 95% CI, 1.75-2.97) and PE-related (OR, 3.64; 95% CI, 2.01-6.59) mortality but not stroke. Findings were similar in multivariable analyses. Conclusions In patients with acute symptomatic PE, both preexisting AF and incident AF predict adverse clinical outcomes. The type of adverse outcomes may differ depending on the timing of AF onset.info:eu-repo/semantics/publishedVersio
Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years
publishersversionPeer reviewe
- âŠ